Phase II Trial of Carboplatin, Paclitaxel, Cetuximab and Bevacizumab Followed by Cetuximab and Bevacizumab in Advanced Non-Squamous Non-Small Cell Lung Cancer: SWOG S0536

INTRODUCTION: Cetuximab and bevacizumab have each been demonstrated to prolong survival when added to chemotherapy in patients with advanced non-small cell lung cancer (NSCLC). However, the potential benefit of combining cetuximab and bevacizumab together with a platinum-based doublet had not been e...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Kim, Edward S., Moon, James, Herbst, Roy S., Redman, Mary W., Dakhil, Shaker R., Velasco, Mario R., Hirsch, Fred R., Mack, Philip C., Kelly, Karen, Heymach, John V., Gandara, David R.
Формат: Artigo
Язык:Inglês
Опубликовано: 2013
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4072123/
https://ncbi.nlm.nih.gov/pubmed/24189513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0000000000000009
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы